A correlation between RelB and NF-κB2 expression with clinicopathological parameters, including a patient's race, gender, age, weight, tumor grade, cancer stage, and nodal metastasis status, revealed significant upregulation of RelB and NF-κB2 in HCC, relative to normal liver tissues (Figure 4). This evidence concerns the gene NFKB2 and hepatocellular carcinoma.